| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/16/2008 | EP1942895A1 Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects |
| 07/16/2008 | EP1942886A1 New crystalline form of perindopril erbumine |
| 07/16/2008 | EP1517890B1 Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof |
| 07/16/2008 | EP1506205B1 Novel azacyclic ethynyl derivatives |
| 07/16/2008 | EP1471907B1 Use of c-kit inhibitors for treating autoimmune diseases |
| 07/16/2008 | EP1426051B1 Medicinal composition for prevention of or treatment for cerebrovascular disorder |
| 07/16/2008 | EP1392655B1 Potassium channel openers |
| 07/16/2008 | EP1305006B1 Process for the manufacture of dispersions for formulating slightly or poorly soluble active ingredients |
| 07/16/2008 | EP1294383B1 Oral compositions comprising antimicrobial agents for the prevention of systemic diseases |
| 07/16/2008 | EP1265603B1 Il-8 receptor antagonists |
| 07/16/2008 | CN101223443A Method for evaluating the effects of smoke on bronchioles |
| 07/16/2008 | CN101223184A Glucuronidated nebivolol metabolites |
| 07/16/2008 | CN101223163A New 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 07/16/2008 | CN101223158A N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives |
| 07/16/2008 | CN101223140A Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity |
| 07/16/2008 | CN101222931A Cynara scolymus extracts, the use thereof and formulations containing them |
| 07/16/2008 | CN101220065A Novel scutellarin compounds and uses thereof |
| 07/16/2008 | CN101220064A Novel scutellaria glycosides compounds and uses thereof |
| 07/16/2008 | CN101220006A Buflomedil production method |
| 07/16/2008 | CN101219994A Ozagrel ester, composition and production method thereof |
| 07/16/2008 | CN101219992A Crystalline forms of pitavastatin calcium |
| 07/16/2008 | CN101219963A Phenylcarbinol kearny ester compounds |
| 07/16/2008 | CN101219213A Medical preparations for the treatment of alpha-galactosidase a deficiency |
| 07/16/2008 | CN101219204A Combinations comprising a low molecular weight thrombin inhibitor and a prodrug of a low molecular weight thrombin inhibitor |
| 07/16/2008 | CN101219187A Method for preparing Chinese medicine of condensed pill for preventing brain decline |
| 07/16/2008 | CN101219183A Application of mangosteen rind extract in preparing medicament for treating myocardial ischemia |
| 07/16/2008 | CN101219180A Health care wine and its processing method |
| 07/16/2008 | CN101219179A Chinese composition medicine for treating piles and method of preparing the same |
| 07/16/2008 | CN101219174A Medicine for treating rheumatic heart disease |
| 07/16/2008 | CN101219161A Dracocephalum moldavica extract and dracocephalum moldavica dropping pills, and method of preparing the same |
| 07/16/2008 | CN101219145A Quinazoline derivatives as VEGF inhibitors |
| 07/16/2008 | CN101219132A Method for applying calcium polyenoic acid for medical and beauty treatment fields |
| 07/16/2008 | CN101219131A Method for applying calcium polyenoic acid for medical and beauty treatment fields |
| 07/16/2008 | CN101219129A Application of sodium ferulic acid in preparing medicament for expanding vascellum |
| 07/16/2008 | CN101219122A Hydrochloric acid glitazone dispersion piece and its preparation method |
| 07/16/2008 | CN101219120A Telmisartan dispersible tablet and method for preparing the same |
| 07/16/2008 | CN100402654C Method of treating ischemic disease |
| 07/16/2008 | CN100402543C Preparation method of hyperin and hypericin of Hypericum perforatum |
| 07/16/2008 | CN100402521C 4-imidazolin-2-one compounds |
| 07/16/2008 | CN100402517C 9-anthrone lactone compounds, preparing method and use thereof |
| 07/16/2008 | CN100402515C Substituted phthalides as anti-convulsive drugs |
| 07/16/2008 | CN100402510C Oxazole derivatives and their use as insulin sensitizers |
| 07/16/2008 | CN100402506C Ozagrel lysine, preparing method and usage |
| 07/16/2008 | CN100402502C Crystalline form gamma of the chlorhydrate of ivabradine, process for its preparation and phamaceutical composition containing it |
| 07/16/2008 | CN100402499C 2-iminopyrrolidine derivatives |
| 07/16/2008 | CN100402496C Compounds useful as matrix metalloprotease inhibitors |
| 07/16/2008 | CN100402495C Aminoalkylamide substituted cyclohexyl derivatives |
| 07/16/2008 | CN100402060C Heart beneficial keton dispersion tablet and its preparation method |
| 07/16/2008 | CN100402058C Quality control method of compound polygonium oriental preparation |
| 07/16/2008 | CN100402053C Method for quality control of traditional Chinese medicine prepns. |
| 07/16/2008 | CN100402045C Starfish and seaweed compound product and its preparing method |
| 07/16/2008 | CN100402026C Use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases |
| 07/16/2008 | CN100402025C Modified release pharmaceutical formulation |
| 07/15/2008 | US7399878 Pharmaceutical compounds |
| 07/15/2008 | US7399829 Variants of RANKL protein |
| 07/15/2008 | US7399780 pyridin-2-yl-1H-indole or pyrimidin-4-yl-1H-indole derivatives; enzyme inhibitor of glycogen synthase kinase-3; treating dementia, Alzheimer's Disease, Parkinson's Disease, amyotrophic lateral sclerosis, corticobasal degeneration, Down syndrome, Huntington's Disease |
| 07/15/2008 | US7399770 N-(hydroxy)-2-(4'-chlorobiphenyl-4-sulfonyl)-4-hydroxy-1,2,3,4-tetrahydrobenzo[4,5]thieno[3,2-c]pyridine-1-carboxamide; collagenase inhibitor; antiinflammatory, angiogenesis agent, wound healing agent; arthritis, multiple sclerosis, osteoarthrosis, atherosclerosis, restenosis, myocardial infarction |
| 07/15/2008 | US7399759 1, 3-benzothiazinone derivatives and use thereof |
| 07/15/2008 | US7399750 Methods for cardiac gene transfer |
| 07/15/2008 | US7399604 Methods and products related to evaluating the quality of a polysaccharide |
| 07/15/2008 | US7399485 Rapidly Disintegrable solid preparation |
| 07/15/2008 | US7399472 Vaccines |
| 07/15/2008 | US7399464 Polypeptides of the IFNα-7 gene |
| 07/15/2008 | US7399463 HSA-free formulations of interferon-beta |
| 07/15/2008 | CA2425560C Anticholinergics, processes for preparing them and their use as pharmaceutical compositions |
| 07/15/2008 | CA2362515C Utilization of material containing docosapentaenoic acid |
| 07/15/2008 | CA2362271C Essential fatty acids in the prevention of cardiovascular events |
| 07/15/2008 | CA2361237C Lyophilisates having improved reconstitutibility |
| 07/15/2008 | CA2315258C Neuroprotective agents |
| 07/15/2008 | CA2282184C Stable, pulverulent lycopene formulations, comprising lycopene having a degree of crystallinity of greater than 20% |
| 07/15/2008 | CA2271857C Method for treating symptoms of diabetes |
| 07/15/2008 | CA2247848C Nitric oxide donors capable of reducing toxicity from drugs |
| 07/15/2008 | CA2113023C Tnf receptor promoter |
| 07/10/2008 | WO2008083124A1 N-substituted-heterocycloalkyloxybenzamide compounds and methods of use |
| 07/10/2008 | WO2008082321A1 Emulsion of perfluoroorganic compounds for medical use and a methods for the preparation and the use thereof |
| 07/10/2008 | WO2008082268A1 Use of root extract of saururus chinensis for manufacture of medicament for vasorelaxation |
| 07/10/2008 | WO2008081989A1 Nerve regeneration agent |
| 07/10/2008 | WO2008081800A1 Liquid seasoning |
| 07/10/2008 | WO2008081754A1 Oil-and-fat composition, and food or beverage containing the oil-and-fat composition |
| 07/10/2008 | WO2008081116A2 Cellular preparations for use as a revascularisation stimulating agent |
| 07/10/2008 | WO2008080973A1 Substituted oxindole derivatives and their use as vasopressin receptor ligands |
| 07/10/2008 | WO2008080972A1 Substituted oxindole derivative and its use as a vasopressin receptor modulator |
| 07/10/2008 | WO2008080971A1 Substituted oxindole derivative and its use as a vasopressin receptor ligand |
| 07/10/2008 | WO2008080970A1 Substituted oxindole derivative and its use as a vasopressin receptor ligand |
| 07/10/2008 | WO2008080844A1 Azaspiro derivatives |
| 07/10/2008 | WO2008080842A1 Indoles |
| 07/10/2008 | WO2008080511A1 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals |
| 07/10/2008 | WO2008080461A1 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazo[4,5-b]pyridin-2-one derivatives useful as a2b adenosine receptor antagonists |
| 07/10/2008 | WO2008061966A3 New use of flibanserin |
| 07/10/2008 | WO2008061247A3 Benzenesulfonanilide compound inhibitors of urea transporters |
| 07/10/2008 | WO2008040774A3 Angiotensin ii receptor antagonist for the treatment of systemic diseases in cats |
| 07/10/2008 | WO2008015558A3 Beta-3 receptor ligands and their use in therapy |
| 07/10/2008 | WO2007149366B1 Prolonged improvement of renal function comprising infrequent administration of an aa1ra |
| 07/10/2008 | WO2006138421A3 Nanoparticulate azelnidipine formulations |
| 07/10/2008 | WO2002072778A3 Method for identifying inhibitors of g protein coupled receptor signaling |
| 07/10/2008 | US20080167609 Methods of treating vascular disease |
| 07/10/2008 | US20080167388 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
| 07/10/2008 | US20080167365 Of the ACE inhibitor ramipril by mixing with the ramipril (m)ethyl ester prodrug and a pressure sensitive adhesive carrier; improved pharmacokinetics; sustained release |
| 07/10/2008 | US20080167364 Ramipril-amine salts |
| 07/10/2008 | US20080167362 Time-release tablets or capsules also containing an opoid or analgesic; cyclooxygenase-2 inhibitors |